Apotheek Leenesonne financials
A multi-period view of the public annual-account figures reported for Apotheek Leenesonne, with comparable measures and links to available source documents.
Company overviewRegistry number
0447847416
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for Apotheek Leenesonne
2025 versus 2024
- Operating line
- €595,872
- EBITDA
- €155,677
- Total assets
- €1,308,479
- Equity
- €838,119
+5.8%
+38.2%
-3.8%
+1.7%
EBITDA margin +26.1% · Equity ratio +64.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €595,872 | €155,677 | €1,308,479 | €838,119 | - |
| 202430 Jun 2024 | €562,944 | €112,620 | €1,359,642 | €823,995 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.